Olivia Burke

Ms. Olivia Burke

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2025 in Skin Appendage Disorders
Verified
Journal Article
Closed access
OBOlivia Burke
Olivia Burke
BSBrianna Sa
Brianna Sa
DCDavid Alvarez Cespedes
David Alvarez Cespedes
ATAntonella Tosti
Antonella Tosti
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an innovative class of medications primarily used to manage type 2 diabetes and obesity. These agents not only improve glycemic control but also promote significant weight loss and reduce cardiovascular risk. Summary: GLP-1RAs are associated with various dermatologic effects, including injection-site reactions and immune-mediated responses such as hypersensitivity, urticaria, and bullous pemphigoid. “Ozempic face,” a term describing facial fat loss, has gained media attention due to its cosmetic implications. Additionally, hair loss, particularly in the form of telogen effluvium, has been observed, potentially linked to rapid weight loss from GLP-1RA use. Emerging evidence also highlights the therapeutic potential of GLP-1RAs in enhancing wound healing and treating inflammatory skin conditions like psoriasis. Key Messages: With the increasing use of GLP-1RAs for weight management, clinicians should remain alert to dermatologic side effects and consider appropriate dermatologic consultations when needed. Further research is essential to optimize the safe and effective use of GLP-1RAs, ensuring therapeutic benefits are maximized while minimizing adverse dermatologic outcomes.

23 January 2025 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
OBOlivia Burke
Olivia Burke
BSBrianna Sa
Brianna Sa
DCDavid Alvarez Cespedes
David Alvarez Cespedes
ASAndrea Sechi
Andrea Sechi
ATAntonella Tosti
Antonella Tosti

1 September 2025 in International Journal of Dermatology
Verified
Journal Article
Closed access
OBOlivia Burke
Olivia Burke
SYSeanna Yang
Seanna Yang
JBJacob Beer
Jacob Beer
KHKyaw Zin Htet
Kyaw Zin Htet
SEScott A. Elman
Scott A. Elman

28 July 2023 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ALAngelina Labib
Angelina Labib
OBOlivia Burke
Olivia Burke
ANAnna Nichols
Anna Nichols
AMAndrea D. Maderal
Andrea D. Maderal

8 February 2025 in Archives of Dermatological Research
Verified
Journal Article
Open access
PDF file
OBOlivia Burke
Olivia Burke
MHMara Hartoyo
Mara Hartoyo
RLRachel Lin
Rachel Lin
RKRobert S. Kirsner
Robert S. Kirsner
SEScott A. Elman
Scott A. Elman
Skin diseases affect millions of Americans, imposing a large financial burden on the U.S. healthcare system annually. Inpatient dermatology is a subspecialty focused on treating complicated skin diseases in hospitalized patients. Utilization of these services enhances diagnostic accuracy, shorten hospital stays, lower readmission rates, and improve patient outcomes. However, studies have indicated an overall decline in inpatient dermatology consultations and dermatology as primary admitting services. Currently, only two academic hospitals in the United States grant dermatologists admitting privileges, indicating decreased exposure to inpatient dermatology in residency despite the need for more hospital-based dermatologists. Therefore, this narrative review aims to characterize the financial impact and utilization of inpatient dermatology services. Historical and recent data consistently highlight the financial benefit of dermatologic hospitalizations and poor utilization of inpatient dermatology consultations. Teledermatology consultations also improve diagnostic accuracy and expedite interventions to improve patient outcomes. However, challenges like reduced reimbursement, lack of protocols, and limited resident training in inpatient dermatology have discouraged dermatologists from providing inpatient consultations. Policy changes are needed to promote these services that benefit patients as well as health systems.

1 January 2025 in Wound Repair and Regeneration
Verified
Journal Article
Open access
OBOlivia Burke
Olivia Burke
RKRobert S. Kirsner
Robert S. Kirsner
SEScott A. Elman
Scott A. Elman
Pressure injuries in critically ill patients present a significant healthcare burden. Traditional methods, such as the Braden score, assess the risk of developing pressure injuries by evaluating factors like sensory perception, moisture and mobility. In contrast, thermographic imaging, which measures variations in skin temperature, offers a promising tool for not only assessing risk but also enabling earlier identification of pressure injuries. This study assessed thermographic imaging's ability to detect existing and evolving pressure injuries in surgical intensive care unit (SICU) patients and compared its accuracy with the Braden score. Among 465 patients, 76 underwent thermographic evaluations of the sacrum and/or heel. Of 25 patients with pressure injuries at admission, 23 had abnormal thermographic scores. Fifteen patient developed pressure injuries during SICU admission. Logistic regression showed that abnormal thermographic scores significantly increased the likelihood of detecting both existing and new injuries, while the Braden score was not a significant predictor. Thermographic imaging appears to be a superior predictor of pressure injuries, offering earlier detection and potentially improving patient outcomes while reducing healthcare costs.